The Oxford Lymphoid Disorder Study Group (OLDSG) will be introduced later this month at a virtual launch event being held on Friday 18 September 2020, 2 – 5 pm.
The group is led by Dr Graham Collins and a steering group, who will be helping to translate and direct lymphoid research in Oxford into patient-focused applications.
The upcoming event on 18 September 2020 falls within Blood Cancer Awareness Month in the UK, and will give those involved in various lymphoid disorder research the opportunity to talk more about their work and how it applies to diseases such as Hodgkin Lymphoma, Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukaemia.
You can sign up for this upcoming event and see the full agenda of talks from top clinicians and researchers in the lymphoid disorder sector, by clicking here.
About the OLDSG
At present, around 3-4% of people will develop either lymphoma or Chronic Lymphocytic Leukemia (CLL) during their lifetime. Together, lymphoma and CLL represent the commonest blood cancer by some margin.
The OLDSG acts as a network to bring together researchers and clinicians from across the University of Oxford and University Hospitals Trust. In doing so, the group hopes to:
- to increase the visibility of lymphoid disorder research in the university
- to foster collaborations between clinicians and laboratory-based scientists leading to high quality translational projects
- to interact with patients and the public at all levels of project development to deliver research which impacts directly on patient need